罕见病药物的可及性：为原发性纤毛运动障碍疾呼
Access to medicines for rare diseases: beating the drum for primary ciliary dyskinesia.
作者信息
Crowley Suzanne, Azevedo Inês, Boon Mieke, Bush Andrew, Eber Ernst, Haarman Eric, Karadag Bulent, Kötz Karsten, Leigh Margaret, Moreno-Galdó Antonio, Mussaffi Huda, Nielsen Kim G, Omran Heymut, Papon Jean-François, Pohunek Petr, Priftis Kostas, Rindlisbacher Bernhard, Santamaria Francesca, Valiulis Arunas, Witt Michal, Yiallouros Panayiotis, Zivkovic Zorica, Kuehni Claudia E, Lucas Jane S
机构信息
Paediatric Dept for Lung and Allergic diseases, Oslo University Hospital, Oslo, Norway.
Centro Materno-Pediátrico, Centro Hospitalar Universitário de S. João, Porto, Portugal.
出版信息
ERJ Open Res. 2020 Sep 14;6(3). doi: 10.1183/23120541.00377-2020. eCollection 2020 Jul.
相似文献
1
Access to medicines for rare diseases: beating the drum for primary ciliary dyskinesia.
ERJ Open Res. 2020 Sep 14;6(3). doi: 10.1183/23120541.00377-2020. eCollection 2020 Jul.
2
Nasal Nitric Oxide Measurement and a Modified PICADAR Score for the Screening of Primary Ciliary Dyskinesia in Adults with Bronchiectasis.
Pneumologie. 2017 Aug;71(8):543-548. doi: 10.1055/s-0043-111909. Epub 2017 Aug 7.
3
Retinitis pigmentosa and bronchiectasis: a case report on a rare association suggestive of a common underlying primary ciliary dyskinesia (PCD).
Bull Soc Belge Ophtalmol. 2010(314):9-14.
4
Primary ciliary dyskinesia in six patients with bronchiectasis.
Pneumonol Alergol Pol. 2016;84(2):109-15. doi: 10.5603/PiAP.2016.0009.
5
Long-term outcome of Tunisian children with primary ciliary dyskinesia confirmed by transmission electron microscopy.
Afr Health Sci. 2016 Dec;16(4):954-961. doi: 10.4314/ahs.v16i4.11.
6
Variation in treatment strategies for the eradication of Pseudomonas aeruginosa in primary ciliary dyskinesia across European centers.
Chron Respir Dis. 2019 Jan-Dec;16:1479972318787919. doi: 10.1177/1479972318787919. Epub 2018 Jul 18.
7
[Primary ciliary dyskinesia in situs inversus without bronchiectasis].
Pneumologie. 1997 Dec;51(12):1127-32.
8
A process of years: coming to terms with primary ciliary dyskinesia.
Breathe (Sheff). 2020 Jun;16(2):200116. doi: 10.1183/20734735.0116-2020.
9
Mannose-binding lectin 2 gene polymorphism and lung damage in primary ciliary dyskinesia.
Pediatr Pulmonol. 2015 Feb;50(2):179-86. doi: 10.1002/ppul.23026. Epub 2014 Apr 19.
10
Diagnosis and management of primary ciliary dyskinesia.
Cilia. 2015 Jan 22;4(1):2. doi: 10.1186/s13630-014-0011-8. eCollection 2015.
引用本文的文献
1
Rhinosinusitis: Evidence and experience - 2024.
Braz J Otorhinolaryngol. 2025 May 19;91(5):101595. doi: 10.1016/j.bjorl.2025.101595.
2
Current and Future Treatments in Primary Ciliary Dyskinesia.
Int J Mol Sci. 2021 Sep 11;22(18):9834. doi: 10.3390/ijms22189834.
本文引用的文献
1
Efficacy and safety of azithromycin maintenance therapy in primary ciliary dyskinesia (BESTCILIA): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial.
Lancet Respir Med. 2020 May;8(5):493-505. doi: 10.1016/S2213-2600(20)30058-8.
2
Azithromycin for primary ciliary dyskinesia: a milestone.
Lancet Respir Med. 2020 May;8(5):429-430. doi: 10.1016/S2213-2600(20)30100-4.
3
A Review of Rare Disease Policies and Orphan Drug Reimbursement Systems in 12 Eurasian Countries.
Front Public Health. 2020 Jan 28;7:416. doi: 10.3389/fpubh.2019.00416. eCollection 2019.
4
Primary ciliary dyskinesia in the genomics age.
Lancet Respir Med. 2020 Feb;8(2):202-216. doi: 10.1016/S2213-2600(19)30374-1. Epub 2019 Oct 14.
5
The Clinical Features of Bronchiectasis Associated with Alpha-1 Antitrypsin Deficiency, Common Variable Immunodeficiency and Primary Ciliary Dyskinesia--Results from the U.S. Bronchiectasis Research Registry.
Chronic Obstr Pulm Dis. 2019 Apr 9;6(2):145-153. doi: 10.15326/jcopdf.6.2.2018.0156.
6
The burden of rare diseases.
Am J Med Genet A. 2019 Jun;179(6):885-892. doi: 10.1002/ajmg.a.61124. Epub 2019 Mar 18.
7
Dornase alfa for cystic fibrosis.
Cochrane Database Syst Rev. 2018 Sep 6;9(9):CD001127. doi: 10.1002/14651858.CD001127.pub4.
8
Lung function in patients with primary ciliary dyskinesia: an iPCD Cohort study.
Eur Respir J. 2018 Aug 23;52(2). doi: 10.1183/13993003.01040-2018. Print 2018 Aug.
9
Variation in treatment strategies for the eradication of Pseudomonas aeruginosa in primary ciliary dyskinesia across European centers.
Chron Respir Dis. 2019 Jan-Dec;16:1479972318787919. doi: 10.1177/1479972318787919. Epub 2018 Jul 18.
10
Extended Interval Tobramycin Pharmacokinetics in a Pediatric Patient With Primary Ciliary Dyskinesia Presenting With an Acute Respiratory Exacerbation.
J Pediatr Pharmacol Ther. 2018 Mar-Apr;23(2):159-163. doi: 10.5863/1551-6776-23.2.159.
Zotero 插件